Foreign-Trade Zone (FTZ) 49-Newark and Elizabeth, New Jersey; Notification of Proposed Production Activity; Catalent Pharma Solutions (Pharmaceutical Products); Somerset, New Jersey, 47166-47167 [2020-16887]
Download as PDF
<![CDATA[
47166
Federal Register / Vol. 85, No. 150 / Tuesday, August 4, 2020 / Notices
DEPARTMENT OF COMMERCE
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
Foreign-Trade Zones Board
[Order No. 2104]
[B–48–2020]
Restricted Approval for Production
Authority/Foreign-Trade Zone 12/Black
& Decker (U.S.), Inc. (Lithium Ion
Battery Assembly for Cordless Power
Tools)/Mission, Texas
Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the
following Order:
jbell on DSKJLSW7X2PROD with NOTICES
Whereas, the Foreign-Trade Zones
(FTZ) Act provides for ‘‘. . . the
establishment . . . of foreign-trade
zones in ports of entry of the United
States, to expedite and encourage
foreign commerce, and for other
purposes,’’ and authorizes the ForeignTrade Zones Board to grant to qualified
corporations the privilege of
establishing foreign-trade zones in or
adjacent to U.S. Customs and Border
Protection ports of entry;
Whereas, the McAllen Foreign Trade
Zone Inc., grantee of Foreign-Trade
Zone 12, has requested production
authority on behalf of Black & Decker
(U.S.), Inc. (Black & Decker), within FTZ
12 in Mission, Texas, (B–68–2019,
docketed October 25, 2019);
Whereas, notice inviting public
comment has been given in the Federal
Register (84 FR 59352, November 4,
2019) and the application has been
processed pursuant to the FTZ Act and
the Board’s regulations; and,
Whereas, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations would be satisfied
and that the proposal would be in the
public interest, if subject to the
restriction listed below;
Now, therefore, the Board hereby
orders:
The application for production
authority under zone procedures within
FTZ 12 on behalf of Black & Decker, as
described in the application and
Federal Register notice, is approved,
subject to the FTZ Act and the Board’s
regulations, including Section 400.13,
and further subject to the following
restriction: The authority shall remain
in effect for a period of five years from
the date of approval by the Board.
Dated: July 26, 2020.
Jeffrey I. Kessler,
Assistant Secretary for Enforcement and
Compliance, Alternate Chairman, ForeignTrade Zones Board.
[FR Doc. 2020–16889 Filed 8–3–20; 8:45 am]
BILLING CODE 3510–DS–P
VerDate Sep<11>2014
18:14 Aug 03, 2020
Jkt 250001
Foreign-Trade Zone (FTZ) 201—
Holyoke, Massachusetts; Notification
of Proposed Production Activity;
ProAmpac Holdings, Inc. (Flexible
Packaging Applications); Westfield,
Massachusetts
ProAmpac Holdings, Inc. (ProAmpac)
submitted a notification of proposed
production activity to the FTZ Board for
its facilities in Westfield, Massachusetts.
The notification conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.22) was
received on July 27, 2020.
ProAmpac already has authority to
produce flexible packaging for food,
medical, pharmaceutical, and other
consumer and industrial applications
within Subzone 201D. The current
request would add finished products to
the scope of authority. Pursuant to 15
CFR 400.14(b), FTZ activity would be
limited to the specific finished products
described in the submitted notification
(as described below) and subsequently
authorized by the FTZ Board.
Production under FTZ procedures
could exempt ProAmpac from customs
duty payments on the foreign-status
materials/components used in export
production (estimated five percent of
production). On its domestic sales,
ProAmpac would be able to choose the
duty rates during customs entry
procedures that apply to: Heavy paper
can liner and pouch/packaging stock—
paper and paperboard, weighing >150g/
m2, with aluminum laminated on one
side, and extruded plastics, with the
paper being the primary layer; paper can
liner and pouch/packaging stock
without plastics—paper with aluminum
laminated on one side with the paper
being the primary layer; paper label
stock—paper and foil laminates used for
labels; laminated aluminum lidding
stock—printed or unprinted aluminum,
laminated with a plastic coating;
aluminum laminated packaging stock
without extruded plastics—aluminum
laminated with printed or unprinted
paper or plastic film on one side, with
the aluminum being the primary layer;
and, aluminum food wrap—printed and
unprinted aluminum laminated with
paper in roll form (duty rates ranges
from duty-free to 3.7%). ProAmpac
would be able to avoid duty on foreignstatus components which become scrap/
waste. Customs duties also could
possibly be deferred or reduced on
foreign-status production equipment.
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
There are no new materials/
components included in this
notification.
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
September 14, 2020.
A copy of the notification will be
available for public inspection in the
‘‘Reading Room’’ section of the Board’s
website, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202)
482–1963.
Dated: July 29, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020–16890 Filed 8–3–20; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–47–2020]
Foreign-Trade Zone (FTZ) 49—Newark
and Elizabeth, New Jersey; Notification
of Proposed Production Activity;
Catalent Pharma Solutions
(Pharmaceutical Products); Somerset,
New Jersey
Catalent Pharma Solutions (Catalent)
submitted a notification of proposed
production activity to the FTZ Board for
its facility in Somerset, New Jersey. The
notification conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.22) was
received on July 17, 2020.
The applicant indicates that it will be
submitting a separate application for
FTZ designation at the company’s
facility under FTZ 49. The facility is
used for the production of encorafenib
bulk capsules. Pursuant to 15 CFR
400.14(b), FTZ activity would be limited
to the specific foreign-status material
and specific finished product described
in the submitted notification (as
described below) and subsequently
authorized by the FTZ Board.
Production under FTZ procedures
could exempt Catalent from customs
duty payments on the foreign-status
material used in export production. On
its domestic sales, for the foreign-status
material noted below, Catalent would be
able to choose the duty rate during
customs entry procedures that applies to
BRAFTOVI (encorafenib bulk capsules)
(duty-free). Catalent would be able to
avoid duty on foreign-status material
E:\FR\FM\04AUN1.SGM
04AUN1
Federal Register / Vol. 85, No. 150 / Tuesday, August 4, 2020 / Notices
which becomes scrap/waste. Customs
duties also could possibly be deferred or
reduced on foreign-status production
equipment.
The material sourced from abroad is
encorafenib API (duty rate 6.5%).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
September 14, 2020.
A copy of the notification will be
available for public inspection in the
‘‘Reading Room’’ section of the Board’s
website, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202)
482–1963.
Dated: July 28, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020–16887 Filed 8–3–20; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
Antidumping or Countervailing Duty
Order, Finding, or Suspended
Investigation; Opportunity To Request
Administrative Review
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
FOR FURTHER INFORMATION CONTACT:
Brenda E. Brown, Office of AD/CVD
Operations, Customs Liaison Unit,
Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230, telephone: (202) 482–4735.
jbell on DSKJLSW7X2PROD with NOTICES
AGENCY:
Background
Each year during the anniversary
month of the publication of an
antidumping or countervailing duty
order, finding, or suspended
investigation, an interested party, as
defined in section 771(9) of the Tariff
Act of 1930, as amended (the Act), may
request, in accordance with 19 CFR
351.213, that the Department of
Commerce (Commerce) conduct an
administrative review of that
antidumping or countervailing duty
order, finding, or suspended
investigation.
All deadlines for the submission of
comments or actions by Commerce
discussed below refer to the number of
calendar days from the applicable
starting date.
VerDate Sep<11>2014
18:14 Aug 03, 2020
Jkt 250001
Respondent Selection
In the event Commerce limits the
number of respondents for individual
examination for administrative reviews
initiated pursuant to requests made for
the orders identified below, Commerce
intends to select respondents based on
U.S. Customs and Border Protection
(CBP) data for U.S. imports during the
period of review. We intend to release
the CBP data under Administrative
Protective Order (APO) to all parties
having an APO within five days of
publication of the initiation notice and
to make our decision regarding
respondent selection within 21 days of
publication of the initiation Federal
Register notice. Therefore, we
encourage all parties interested in
commenting on respondent selection to
submit their APO applications on the
date of publication of the initiation
notice, or as soon thereafter as possible.
Commerce invites comments regarding
the CBP data and respondent selection
within five days of placement of the
CBP data on the record of the review.
In the event Commerce decides it is
necessary to limit individual
examination of respondents and
conduct respondent selection under
section 777A(c)(2) of the Act:
In general, Commerce finds that
determinations concerning whether
particular companies should be
‘‘collapsed’’ (i.e., treated as a single
entity for purposes of calculating
antidumping duty rates) require a
substantial amount of detailed
information and analysis, which often
require follow-up questions and
analysis. Accordingly, Commerce will
not conduct collapsing analyses at the
respondent selection phase of a review
and will not collapse companies at the
respondent selection phase unless there
has been a determination to collapse
certain companies in a previous
segment of this antidumping proceeding
(i.e., investigation, administrative
review, new shipper review or changed
circumstances review). For any
company subject to a review, if
Commerce determined, or continued to
treat, that company as collapsed with
others, Commerce will assume that such
companies continue to operate in the
same manner and will collapse them for
respondent selection purposes.
Otherwise, Commerce will not collapse
companies for purposes of respondent
selection. Parties are requested to (a)
identify which companies subject to
review previously were collapsed, and
(b) provide a citation to the proceeding
in which they were collapsed. Further,
if companies are requested to complete
a Quantity and Value Questionnaire for
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
47167
purposes of respondent selection, in
general each company must report
volume and value data separately for
itself. Parties should not include data
for any other party, even if they believe
they should be treated as a single entity
with that other party. If a company was
collapsed with another company or
companies in the most recently
completed segment of a proceeding
where Commerce considered collapsing
that entity, complete quantity and value
data for that collapsed entity must be
submitted.
Deadline for Withdrawal of Request for
Administrative Review
Pursuant to 19 CFR 351.213(d)(1), a
party that requests a review may
withdraw that request within 90 days of
the date of publication of the notice of
initiation of the requested review. The
regulation provides that Commerce may
extend this time if it is reasonable to do
so. Determinations by Commerce to
extend the 90-day deadline will be
made on a case-by-case basis.
Deadline for Particular Market
Situation Allegation
Section 504 of the Trade Preferences
Extension Act of 2015 amended the Act
by adding the concept of particular
market situation (PMS) for purposes of
constructed value under section 773(e)
of the Act.1 Section 773(e) of the Act
states that ‘‘if a particular market
situation exists such that the cost of
materials and fabrication or other
processing of any kind does not
accurately reflect the cost of production
in the ordinary course of trade, the
administering authority may use
another calculation methodology under
this subtitle or any other calculation
methodology.’’ When an interested
party submits a PMS allegation pursuant
to section 773(e) of the Act, Commerce
will respond to such a submission
consistent with 19 CFR 351.301(c)(2)(v).
If Commerce finds that a PMS exists
under section 773(e) of the Act, then it
will modify its dumping calculations
appropriately.
Neither section 773(e) of the Act nor
19 CFR 351.301(c)(2)(v) set a deadline
for the submission of PMS allegations
and supporting factual information.
However, in order to administer section
773(e) of the Act, Commerce must
receive PMS allegations and supporting
factual information with enough time to
consider the submission. Thus, should
an interested party wish to submit a
PMS allegation and supporting new
factual information pursuant to section
1 See Trade Preferences Extension Act of 2015,
Public Law 114–27, 129 Stat. 362 (2015).
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 85, Number 150 (Tuesday, August 4, 2020)]
[Notices]
[Pages 47166-47167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16887]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-47-2020]
Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey;
Notification of Proposed Production Activity; Catalent Pharma Solutions
(Pharmaceutical Products); Somerset, New Jersey
Catalent Pharma Solutions (Catalent) submitted a notification of
proposed production activity to the FTZ Board for its facility in
Somerset, New Jersey. The notification conforming to the requirements
of the regulations of the FTZ Board (15 CFR 400.22) was received on
July 17, 2020.
The applicant indicates that it will be submitting a separate
application for FTZ designation at the company's facility under FTZ 49.
The facility is used for the production of encorafenib bulk capsules.
Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the
specific foreign-status material and specific finished product
described in the submitted notification (as described below) and
subsequently authorized by the FTZ Board.
Production under FTZ procedures could exempt Catalent from customs
duty payments on the foreign-status material used in export production.
On its domestic sales, for the foreign-status material noted below,
Catalent would be able to choose the duty rate during customs entry
procedures that applies to BRAFTOVI (encorafenib bulk capsules) (duty-
free). Catalent would be able to avoid duty on foreign-status material
[[Page 47167]]
which becomes scrap/waste. Customs duties also could possibly be
deferred or reduced on foreign-status production equipment.
The material sourced from abroad is encorafenib API (duty rate
6.5%).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is September 14,
2020.
A copy of the notification will be available for public inspection
in the ``Reading Room'' section of the Board's website, which is
accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at
[email protected] or (202) 482-1963.
Dated: July 28, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-16887 Filed 8-3-20; 8:45 am]
BILLING CODE 3510-DS-P
